Trials / Conditions / Pancreatic Ductal Adenocarcinoma (mPDAC)
Pancreatic Ductal Adenocarcinoma (mPDAC)
7 registered clinical trials studyying Pancreatic Ductal Adenocarcinoma (mPDAC) — 6 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | OSCAR II STUDY - The ONCObind CTC Removal Study NCT06655142 | ExThera Medical Corporation | N/A |
| Not Yet Recruiting | Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma NCT07516392 | Catholic University of the Sacred Heart | N/A |
| Recruiting | Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT06790602 | University of California, San Diego | Phase 2 |
| Recruiting | Immunoparalysis After Pancreaticoduodenectomy NCT07144917 | Hospices Civils de Lyon | — |
| Not Yet Recruiting | How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Ca NCT07444840 | East Lancashire Hospitals NHS Trust | — |
| Not Yet Recruiting | A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal NCT07481357 | Dong-A ST Co., Ltd. | Phase 1 |
| No Longer Available | Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC NCT07399015 | Endevica Bio | — |